COVID-19 Response

In light of the developments of COVID-19, we want to proactively provide information that may be useful to providers at this time as it relates to screening for colorectal cancer (CRC).

Exact Sciences Laboratories remains fully operational. Plans are in place at all sites to help sustain operations and ensure service for patients during this unprecedented time. Read this letter from our CEO, Kevin Conroy, to learn about what we’re doing as a company to operate safely and effectively.

Because Cologuard®, a non-invasive CRC screening option for average-risk adults 45 and older, can be done entirely at home, testing with Cologuard can continue during the current pandemic, even while people are staying home to avoid exposure to or spreading the virus. After Cologuard is prescribed, the collection kit can be sent directly to the patient’s home and picked up by UPS® without social interaction. As telehealth is evolving to meet the needs of the current environment, we also see the benefit of telehealth in playing a role in CRC screening.  As a result, we are making consumers aware of not only existing resources to discuss CRC screening with Cologuard with their provider, but also information about telehealth in general, and a link to one such third party, independent telehealth provider from whom they may request Cologuard to see if it is right for them.

Below, we seek to answer questions that have emerged about recommending Cologuard during the COVID-19 outbreak.

For additional questions about Cologuard, please call the Customer Care Center 24/7 at 1-844-870-8870.

Why is CRC screening still important during the COVID-19 pandemic?


What does a positive Cologuard® result mean, especially in the current COVID-19 environment?


FAQs for Colorectal Cancer Screening During the COVID-19 pandemic